Mibavademab

Mibavademab is a CHO-expressed humanized antibody that targets LEPR/CD295. Mibavademab is equipped with a huIgG4SP heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.58 kDa. The isotype control for Mibavademab can be referenced as Human IgG4 kappa, Isotype Control (HY-P99003) .

Product Specifications

CAS Number

[2305770-44-7]

UNSPSC

12352203

Target

Neuropeptide Y Receptor

Type

Inhibitory Antibodies

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/mibavademab.html

Purity

99.90

Molecular Weight

(145.58 kDa)

Shipping Conditions

Dry Ice

Storage Conditions

-80°C

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 3

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NSL0806Bo 96 Tests

Bovine Regulated On Activation In Normal T-Cell Expressed And Secreted (RANTES) ELISA Kit

Ask

View Details

51067015 1.0 µg DNA

Zfp647 ORF Vector (Mouse) (pORF)

Ask

View Details

RC207231L2 10 µg

KIAA0090 (EMC1) (NM_015047) Human Tagged Lenti ORF Clone

Ask

View Details

GT16262 100 µg

Purified anti-human CD56 (NCAM) Recombinant

Ask

View Details

NBP2-71464PE 0.1 mL

Mouse Monoclonal HOMER2 Antibody (OTI1D1) [PE]

Ask

View Details

SE1-H5227-1mg 1 mg

Human SECTM1 Protein, His Tag

Ask

View Details